Antonio Calles

机构：Hospital General Universitario Gregorio Marañón

发表论文 240 篇 · 总被引 4158 次 · h-index 34

代表论文

• ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0) (2025 · Annals of Oncology · 被引 55)
• Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial (2025 · Annals of Oncology · 被引 33)
• Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A (2025 · Journal of Thoracic Oncology · 被引 32)
• PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi (2025 · Journal of Thoracic Oncology · 被引 15)
• Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials (2025 · 癌症：英文版 · 被引 12)
• Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study (2025 · Journal of Thoracic Oncology · 被引 12)